Clinical Trials Directory

Trials / Conditions / Plasma Cell Disorder

Plasma Cell Disorder

9 registered clinical trials studyying Plasma Cell Disorder — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingPre-malignant States to Hematologic Malignancies in Firefighters
NCT06870760
Wake Forest University Health Sciences—
RecruitingSubcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
NCT07075510
University of Maryland, BaltimorePhase 1 / Phase 2
RecruitingHigh Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
NCT06313502
University of ArkansasPhase 1
Not Yet RecruitingDisease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalitie
NCT06330896
Siriraj Hospital—
RecruitingStudy to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
NCT04879043
Heidelberg Pharma AGPhase 1 / Phase 2
CompletedEvaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer
NCT05032339
Becton, Dickinson and Company—
Active Not RecruitingHaploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
NCT03480360
Dartmouth-Hitchcock Medical CenterPhase 3
CompletedNovel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma
NCT02274519
Mayo ClinicN/A
CompletedInvestigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias
NCT02041325
Boston VA Research Institute, Inc.Phase 2